Idiopathic Acquired Osteosclerosis in a Middle-Aged Woman With Systemic Lupus Erythematosus

Abstract

Widely distributed osteosclerosis is an unusual radiographic finding with multiple causes. A 42-year-old premenopausal Spanish woman gradually acquired dense bone diffusely affecting her axial skeleton and focally affecting her proximal long bones. Systemic lupus erythematosus (SLE) diagnosed in adolescence had been well controlled. She had not fractured or received antiresorptive therapy, and she was hepatitis C virus antibody negative. Family members had low bone mass. Lumbar spine bone mineral density (BMD) measured by dual-photon absorptiometry (DPA) at age 17 years, while receiving glucocorticoids, was 79% the average value of age-matched controls. From ages 30 to 37 years, dual-energy X-ray absorptiometry (DXA) BMD Z-scores steadily increased in her lumbar spine from þ3.8 to þ7.9, and in her femoral neck from -1.4 to -0.7. Serum calcium and phosphorus levels were consistently normal, 25-hydroxyvitamin D (25OHD) <20 ng/mL, and parathyroid hormone (PTH) sometimes slightly increased. Her reduced estimated glomerular filtration rate (eGFR) was 38 to 55 mL/min. Hypocalciuria likely reflected positive mineral balance. During increasing BMD, turnover markers (serum bone-specific alkaline phosphatase [ALP], procollagen type 1 N propeptide [P1NP], osteocalcin [OCN], and carboxy-terminal cross-linking telopeptide of type 1 collagen [CTx], and urinary amino-terminal cross-linking telopeptide of type 1 collagen [NTx and CTx]) were 1.6-to 2.8-fold above the reference limits. Those of bone formation seemed increased more than those of resorption. FGF-23 was slightly elevated, perhaps from kidney disease. Serum osteoprotegerin (OPG) and TGFb1 levels were normal, but sclerostin (SOST) and receptor activator of nuclear factor kappa-B ligand (RANKL) were elevated. Serum multiplex biomarker profiling confirmed a high level of SOST and RANKL, whereas Dickkopf-1 (DKK-1) seemed low. Matrix metalloproteinases-3 (MMP-3) and -7 (MMP-7) were elevated. Iliac crest biopsy revealed tetracycline labels, no distinction between thick trabeculae and cortical bone, absence of peritrabecular fibrosis, few osteoclasts, and no mastocytosis. Then, for the past 3 years, BMD Z-scores steadily decreased. Skeletal fluorosis, mastocytosis, myelofibrosis, hepatitis C-associated osteosclerosis, multiple myeloma, and aberrant phosphate homeostasis did not explain her osteosclerosis. Mutation analysis of the LRP5, LRP4, SOST, and osteopetrosis genes was negative. Microarray showed no notable copy number variation. Perhaps her osteosclerosis reflected an interval of autoimmune-mediated resistance to SOST and/or RANKL.

Gnathodiaphyseal dysplasia: Severe atypical presentation with novel heterozygous mutation of the anoctamin gene (ANO5)

“…Serum multiplex biomarker profiling (SMBP) was performed in 2013 in one comprehensive “batch” assay at Amgen, Inc. (Thousand Oaks, CA, USA) using our published methodology (20–22) and fasting serum acquired from the patient in 2011 and from 20 healthy children (6 boys and 14 girls) obtained in St. Louis, MO, USA in 2012 (Supporting Appendix).…”

Absence of an osteopetrosis phenotype in IKBKG (NEMO) mutation-positive women: A case-control study

“…[19][20][21][22][23][24] Generalized osteosclerosis with increased BDM can occur in skeletal dysplasia, infectious or neoplastic diseases. [25] In osteopetrosis (OPT), increased BMD results from impaired Oc activity, sometimes due to decreased number of these cells. An OPT bone phenotype was described in 2001 by Döffinger et al [19] in two brothers with an IKBKG missense mutation and generalized osteosclerosis, and that same year bone fractures were reported in a two-year-old boy with a nonsense IKBKG mutation.…”

Antimicrobial coatings for orthopaedic implants that accurately releases antibiotic according to pH values in an acidic microenvironment

“…So a new Ph-responsive antibacterial coating was prepared using layer by layer assembly technology in this experiment. Tannic acid (TA) is a natural phenolic hydroxyl molecule that has high ROS scavenging ability and biocompatibility as well as the possibility of being functionalized 42 . As an aminoglycoside antibiotic, gentamicin is commonly used for the treatment of Gram-positive and Gram-negative infections 43 .…”